FIVE-YEAR OUTCOMES OF INTRAVITREAL RANIBIZUMAB FOR CHOROIDAL NEOVASCULARIZATION IN PATIENTS WITH PATHOLOGIC MYOPIA-Reference-Cited by-同舟云学术

FIVE-YEAR OUTCOMES OF INTRAVITREAL RANIBIZUMAB FOR CHOROIDAL NEOVASCULARIZATION IN PATIENTS WITH PATHOLOGIC MYOPIA

Published:2019-07 Issue:7 Volume:39 Page:1289-1298
ISSN:0275-004X
Container-title:Retina
language:en
Short-container-title:

Author:

Onishi Yuka,Yokoi Tae,Kasahara Kaori,Yoshida Takeshi,Nagaoka Natsuko,Shinohara Kosei,Kaneko Yuichiro,Suga Mitsuki,Uramoto Kengo,Ohno-Tanaka Akiko,Ohno-Matsui Kyoko

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Ophthalmology,General Medicine

Reference21 articles.

1. Updates of pathologic myopia;Ohno-Matsui;Prog Retin Eye Res,2016

2. Long-term pattern of progression of myopic maculopathy: a natural history study;Hayashi;Ophthalmology,2010

3. Epidemiology and disease burden of pathologic myopia and myopic choroidal neovascularization: an evidence-based systematic review;Wong;Am J Ophthalmol,2014

4. Myopic choroidal neovascularization: a 10-year follow-up;Yoshida;Ophthalmology,2003

5. Myopic choroidal neovascularization: natural course and treatment;Ohno-Matsui;Curr Opin Ophthalmol,2004

Cited by 24 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Prognostic factors for intravitreal conbercept in the treatment of choroidal neovascularization secondary to pathological myopia;International Ophthalmology;2024-06-22

2. Incidence and Risk Factors of Second Eye Involvement in Myopic Macular Neovascularization;Ophthalmology Retina;2023-11

3. TEN-YEAR VISUAL OUTCOME AND CHANGE IN CHORIORETINAL ATROPHY AFTER INTRAVITREAL RANIBIZUMAB FOR MACULAR NEOVASCULARIZATION IN PATHOLOGIC MYOPIA;Retina;2023-11

4. Management of Myopic Maculopathy: A Review;Turkish Journal of Ophthalmology;2023-10-19

5. Ten-year outcomes of intravitreal injection of ranibizumab for the treatment of myopic choroidal neovascularization: a retrospective study;2023-09-01